The earnings crunch continues this week.
Among the highlights will be scheduled quarterly reports from Exxon Mobil and Chevron, from Bristol-Myers Squibb and Merck, from Time Warner and Viacom, and also from Twitter.
Early Thursday, Exxon Mobil (NYSE: XOM) is expected to say that it had earnings per share (EPS) of $1.88 and that revenue totaled $109.76 billion in the first quarter. That would compare to $2.12 per share earnings and $108.81 billion in revenue in the year-ago period. Note that consensus EPS estimate was higher, at $1.93, just 60 days ago.
Chevron (NYSE: CVX) and ConocoPhillips (NYSE: COP) also step into the earnings spotlight this week. Analysts are looking for EPS from the former to have declined from $3.18 a year ago to $2.52 in the most recent quarter when it reports Friday. The forecast for the latter has EPS up almost nine percent to $1.56 in its report Thursday.
Revenue for the first quarter is expected to have shrunk about four percent to $54.47 billion at Chevron and to have risen more than three percent to $15.13 billion for Conoco. Both companies so far are expected to show some growth on the top and bottom lines in the current quarter.
In addition, Dominion Resources, National Oilwell Varco, Southern Company, Valero Energy and Williams Companies are expected to show earnings gains this week, while EPS are believed to be lower at BP, Marathon Petroleum, Phillips 66 and Royal Dutch Shell. A wider net loss is predicted for Alpha Natural Resources.
See also: Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report
Before the markets open Tuesday, the earnings spotlight shines on Bristol-Myers Squibb (NYSE: BMY) and Merck (NYSE: MRK). Earnings are expected to have grown marginally to $0.43 for the former and to have declined by about seven percent to $0.79 for the latter.
For revenues , the forecasts see $3.89 billion from Bristol-Myers, again up marginally, as well as $10.44 billion from Merck, or more than two percent lower than a year ago. So far, both are expected to show decreasing revenue in the current quarter and for the full year.
Also look for earnings gains from Mylan, Pharmacyclics, Sanofi and Teva Pharmaceutical this week, as well as for wider net losses from BioMarin, Incyte and Seattle Genetics.
Time Warner (NYSE: TWX) steps onto the earnings stage Wednesday morning, followed by Viacom (NASDAQ: VIAB) early Thursday. Analysts are looking for EPS from the former to have increased more than 13 percent year-on-year to $0.88 in the most recent quarter. The forecast for the latter calls for EPS growth of more than seven percent to $1.04.